Southland Equity Partners’s Thermo Fisher Scientific TMO Stock Holding History

Southland Equity Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$221K	Buy	+327	New	+$194K	0.04%	281

Other funds holding TMO

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return

GIA

Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.91B AUM 26.66% 1-Year Est. Return

CIPU

Caledonia Investments plc (UK) London England, United Kingdom $890M AUM 1.23% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Southland Equity Partners's TMO Position: Q3 2026 in Review

Southland Equity Partners opened a new position in Thermo Fisher Scientific (TMO) in Q3 2026: 327 shares worth $221K. The stake represents 0.04% of the portfolio and ranks #281 among its holdings.

366 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

Southland Equity Partners held 327 shares of Thermo Fisher Scientific worth $221K as of Q3 2026.
Thermo Fisher Scientific was a new Southland Equity Partners position in Q3 2026.
Thermo Fisher Scientific made up 0.04% of Southland Equity Partners's portfolio in Q3 2026, its #281 holding.
366 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Southland Equity Partners's 13F filing for Q3 2026, filed 14 Oct 2026.